← FDA DRUG APPROVALS

FDA ANDA · ANDA075486

FAMOTIDINE

Sponsor: HIKMA

APPLICATION
ANDA075486
TYPE
ANDA
ORIGINAL APPROVAL
2001-04-16
LATEST ACTION
2021-09-22
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

FAMOTIDINE PRESERVATIVE FREEPrescription
FAMOTIDINE 10MG/ML · INJECTABLE · INJECTION

Approval history

2021-09-22Labeling · Supplement 17 · standardAP
2008-05-20Labeling · Supplement 7AP
2002-11-08Manufacturing (CMC) · Supplement 2AP
2001-04-16OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →